REVIEW
Add like
Add dislike
Add to saved papers

Germinal cell tumors of the testis after orchiopexy.

A review of the literature revealed 220 cases of germinal cell tumor of the testis that has occurred after orchiopexy. Of these cases 97 were accurately documented in regard to scrotal placement of the undescended testis and the subsequent tumor. Only 6 cases were reported after orchiopexy in children less than 10 years old. Since the number of patients at risk is unknown the possible protection of early orchiopexy against subsequent malignant degeneration cannot be established. The small number of cases reported after orchiopexy in children less than 10 years old is encouraging. The accumulated reports of germinal cell tumors of the testes after orchiopexy in patients between 10 and 20 years old militate against such a procedure in patients with a unilateral underscended testis.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app